by University of Michigan In three of the 21 cases Joshi Alumkal and his team studied, the gene expression of the prostate tumors changed after receiving enzalutamide and no longer had the androgen receptor (shown in red) as an engine. Credit: Joshi Alumkal Drugs like enzalutamide that inhibit male hormones from activating the androgen receptor...
